Cargando…
Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study
BACKGROUND: Bladder cancer patients receiving methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy are co-administered with dexamethasone as an anti-emetic. We examined whether or not dexamethasone affects the severity and onset day of MVAC-induced severe neutropenia. METHODS: Thi...
Autores principales: | Itai, Shingo, Suga, Yukio, Hara, Yusuke, Izumi, Kouji, Maeda, Yuji, Kitagawa, Yasuhide, Ishizaki, Junko, Shimada, Tsutomu, Mizokami, Atsushi, Sai, Yoshimichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225533/ https://www.ncbi.nlm.nih.gov/pubmed/28097015 http://dx.doi.org/10.1186/s40780-016-0072-5 |
Ejemplares similares
-
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
por: Lee, Franklin C., et al.
Publicado: (2013) -
Remarkable Response to Neoadjuvant Therapy with Methotrexate, Vinblastine, Adriamycin, and Cisplatin for Undifferentiated Bladder Carcinoma: A Case Report and Literature Review
por: Numahata, Kenji, et al.
Publicado: (2014) -
Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)
por: Kim, Ki Hong, et al.
Publicado: (2015) -
Vinblastine: Neutropenia and thrombocytopenia: case report
Publicado: (2021) -
Multiday corticosteroids in cancer chemotherapy delay the diagnosis of and antimicrobial administration for febrile neutropenia: a double-center retrospective study
por: Uda, Hiroki, et al.
Publicado: (2019)